Selected research
Industry Research
NK Cells Industry Research Report 2026
Market perspective
The global NK Cells market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for NK Cells is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for NK Cells is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of NK Cells include Affimed NV, Altor BioScience, Chipscreen Biosciences, Fortress Biotech, Henry Ford Health Services, Innate Pharma, NantKwest, NKT and Sorrento Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global NK Cells market in terms of revenue (US$ million) and, where applicable, sales volume (g), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/g) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NK Cells Market by Company
Affimed NV
Altor BioScience
Chipscreen Biosciences
Fortress Biotech
Henry Ford Health Services
Innate Pharma
NantKwest
NKT
Sorrento Therapeutics
Bristol-Myers Squibb
Takeda
NK Cells Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others
NK Cells Segment by Application
Cancer
Cardiovascular Diseases
Others
NK Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NK Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of NK Cells manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of NK Cells by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of NK Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mogamulizumab
- Lorvotuzumab Mertansine
- Others
Applications
- Cancer
- Cardiovascular Diseases
- Others
Companies covered
- Affimed NV
- Altor BioScience
- Chipscreen Biosciences
- Fortress Biotech
- Henry Ford Health Services
- Innate Pharma
- NantKwest
- NKT
- Sorrento Therapeutics
- Bristol-Myers Squibb
- Takeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global NK Cells Market Size (2021-2032)
- 2.2.2 Global NK Cells Sales (2021-2032)
- 2.2.3 Global NK Cells Market Average Price (2021-2032)
- 2.3 NK Cells by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mogamulizumab
- 2.3.3 Lorvotuzumab Mertansine
- 2.3.4 Others
- 2.4 NK Cells by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer
- 2.4.3 Cardiovascular Diseases
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global NK Cells Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global NK Cells Sales (g) of Manufacturers (2021-2026)
- 3.3 Global NK Cells Revenue of Manufacturers (2021-2026)
- 3.4 Global NK Cells Average Price by Manufacturers (2021-2026)
- 3.5 Global NK Cells Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of NK Cells, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of NK Cells, Product Type & Application
- 3.8 Global Manufacturers of NK Cells, Established Date
- 3.9 Global NK Cells Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Affimed NV
- 4.1.1 Affimed NV Company Information
- 4.1.2 Affimed NV Business Overview
- 4.1.3 Affimed NV NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Affimed NV NK Cells Product Portfolio
- 4.1.5 Affimed NV Recent Developments
- 4.2 Altor BioScience
- 4.2.1 Altor BioScience Company Information
- 4.2.2 Altor BioScience Business Overview
- 4.2.3 Altor BioScience NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Altor BioScience NK Cells Product Portfolio
- 4.2.5 Altor BioScience Recent Developments
- 4.3 Chipscreen Biosciences
- 4.3.1 Chipscreen Biosciences Company Information
- 4.3.2 Chipscreen Biosciences Business Overview
- 4.3.3 Chipscreen Biosciences NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Chipscreen Biosciences NK Cells Product Portfolio
- 4.3.5 Chipscreen Biosciences Recent Developments
- 4.4 Fortress Biotech
- 4.4.1 Fortress Biotech Company Information
- 4.4.2 Fortress Biotech Business Overview
- 4.4.3 Fortress Biotech NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fortress Biotech NK Cells Product Portfolio
- 4.4.5 Fortress Biotech Recent Developments
- 4.5 Henry Ford Health Services
- 4.5.1 Henry Ford Health Services Company Information
- 4.5.2 Henry Ford Health Services Business Overview
- 4.5.3 Henry Ford Health Services NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Henry Ford Health Services NK Cells Product Portfolio
- 4.5.5 Henry Ford Health Services Recent Developments
- 4.6 Innate Pharma
- 4.6.1 Innate Pharma Company Information
- 4.6.2 Innate Pharma Business Overview
- 4.6.3 Innate Pharma NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Innate Pharma NK Cells Product Portfolio
- 4.6.5 Innate Pharma Recent Developments
- 4.7 NantKwest
- 4.7.1 NantKwest Company Information
- 4.7.2 NantKwest Business Overview
- 4.7.3 NantKwest NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 NantKwest NK Cells Product Portfolio
- 4.7.5 NantKwest Recent Developments
- 4.8 NKT
- 4.8.1 NKT Company Information
- 4.8.2 NKT Business Overview
- 4.8.3 NKT NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 NKT NK Cells Product Portfolio
- 4.8.5 NKT Recent Developments
- 4.9 Sorrento Therapeutics
- 4.9.1 Sorrento Therapeutics Company Information
- 4.9.2 Sorrento Therapeutics Business Overview
- 4.9.3 Sorrento Therapeutics NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sorrento Therapeutics NK Cells Product Portfolio
- 4.9.5 Sorrento Therapeutics Recent Developments
- 4.10 Bristol-Myers Squibb
- 4.10.1 Bristol-Myers Squibb Company Information
- 4.10.2 Bristol-Myers Squibb Business Overview
- 4.10.3 Bristol-Myers Squibb NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bristol-Myers Squibb NK Cells Product Portfolio
- 4.10.5 Bristol-Myers Squibb Recent Developments
- 4.11 Takeda
- 4.11.1 Takeda Company Information
- 4.11.2 Takeda Business Overview
- 4.11.3 Takeda NK Cells Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Takeda NK Cells Product Portfolio
- 4.11.5 Takeda Recent Developments
5 Global NK Cells Market Scenario by Region
- 5.1 Global NK Cells Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global NK Cells Sales by Region: 2021-2032
- 5.2.1 Global NK Cells Sales by Region: 2021-2026
- 5.2.2 Global NK Cells Sales by Region: 2027-2032
- 5.3 Global NK Cells Revenue by Region: 2021-2032
- 5.3.1 Global NK Cells Revenue by Region: 2021-2026
- 5.3.2 Global NK Cells Revenue by Region: 2027-2032
- 5.4 North America NK Cells Market Facts & Figures by Country
- 5.4.1 North America NK Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America NK Cells Sales by Country (2021-2032)
- 5.4.3 North America NK Cells Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe NK Cells Market Facts & Figures by Country
- 5.5.1 Europe NK Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe NK Cells Sales by Country (2021-2032)
- 5.5.3 Europe NK Cells Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific NK Cells Market Facts & Figures by Country
- 5.6.1 Asia Pacific NK Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific NK Cells Sales by Country (2021-2032)
- 5.6.3 Asia Pacific NK Cells Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America NK Cells Market Facts & Figures by Country
- 5.7.1 South America NK Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America NK Cells Sales by Country (2021-2032)
- 5.7.3 South America NK Cells Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa NK Cells Market Facts & Figures by Country
- 5.8.1 Middle East and Africa NK Cells Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa NK Cells Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa NK Cells Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global NK Cells Sales by Type (2021-2032)
- 6.1.1 Global NK Cells Sales by Type (2021-2032) & (g)
- 6.1.2 Global NK Cells Sales Market Share by Type (2021-2032)
- 6.2 Global NK Cells Revenue by Type (2021-2032)
- 6.2.1 Global NK Cells Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global NK Cells Revenue Market Share by Type (2021-2032)
- 6.3 Global NK Cells Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global NK Cells Sales by Application (2021-2032)
- 7.1.1 Global NK Cells Sales by Application (2021-2032) & (g)
- 7.1.2 Global NK Cells Sales Market Share by Application (2021-2032)
- 7.2 Global NK Cells Revenue by Application (2021-2032)
- 7.2.1 Global NK Cells Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global NK Cells Revenue Market Share by Application (2021-2032)
- 7.3 Global NK Cells Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 NK Cells Value Chain Analysis
- 8.1.1 NK Cells Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 NK Cells Production Mode & Process
- 8.2 NK Cells Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 NK Cells Distributors
- 8.2.3 NK Cells Customers
9 Global NK Cells Analyzing Market Dynamics
- 9.1 NK Cells Industry Trends
- 9.2 NK Cells Industry Drivers
- 9.3 NK Cells Industry Opportunities and Challenges
- 9.4 NK Cells Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst